SCIENTIST (POST-DOCTORAL LEVEL)
Standort: Campus Vienna Biocenter 3, 1030 Vienna
Art: Vollzeit
Firma: Haplogen Bioscience GmbH
Eingetragen am: 2019-02-25
Kontakt:
Beschreibung:

Scientist (post-doctoral level)

full-time position available

Haplogen Bioscience is a Vienna-based biotechnology company that operates in the field of early stage drug discovery with a strong focus on infectious disease. We have a commitment to rigorous scientific quality and an active policy of high impact publications. Our team is young and dynamic and we are collaborating with top scientific institutions and industrial partners worldwide.

We are looking for a highly motivated Scientist in the area of Molecular and Cell Biology, preferably with experience in the areas inflammation, obesity and metabolism.

The successful candidate must hold a PhD or MD with a proven track record in the indicated fields. Your key responsibilities include the investigation of molecular mechanisms and validation of therapeutic drug targets in cell culture models and in vivo.

Strong commitment, the ability to work independently and reliably, a professional, international mind set, as well as an excellent team spirit are essential. Previous experience with relevant animal models is a plus.The successful applicants will be part of a small and very dedicated team involved in exciting projects in the area of drug target identification/validation and early stage drug discovery. Your project will be driven by basic research with a strong translational aspect. Participation in international scientific conferences will be encouraged.

Haplogen is situated at the Campus Vienna BioCenter, a hot spot for life sciences in Austria with renowned basic research institutions such as the IMP, the GMI, and the IMBA and many biotechnology companies. Vienna has been rated as the top city in the world for quality of life for the ninth year in a row.

If you are interested to work with us, please send your application, including cover letter, curriculum vitae and names and contact information of three references to Ms. Kim Le (office@haplogen-bioscience.com) no later than March 11, 2019.

For more information about Haplogen visit http://www.haplogen.com

 

Anhang: hier